INTERNATIONAL TRADE COMMISSION ISSUES NOTICE: CERTAIN SELECTIVE THYROID HORMONE RECEPTOR-BETA AGONISTS, PROCESSES FOR MANUFACTURING OR RELATING TO SAME, AND PRODUCTS CONTAINING SAME; NOTICE OF A COMMISSION DETERMINATION TO REVIEW A FINAL INITIAL DETERMINATION FINDING A VIOLATION OF SECTION 337; REQUEST FOR WRITTEN SUBMISSIONS ON REMEDY, THE PUBLIC INTEREST, AND BONDING

WASHINGTON, Feb. 19 -- International Trade Commission has issued a notice called: Certain Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating to Same, and Products Containing Same; Notice of a Commission Determination To Review a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions on Remedy, the Public Interest, and Bonding.

The notice was published in the Federal Register on Feb. 19 by Lisa Barton, Secretary to the Commission.

Summary: Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to review a final initial determination ("FID") issued by the presiding Chief Administrative Law Judge ("Chief ALJ"), finding a...